Xenetic Biosciences, Inc. (XBIO)
4.20
-0.08
(-1.87%)
USD |
NASDAQ |
Sep 09, 16:00
4.20
0.00 (0.00%)
After-Hours: 16:08
Xenetic Biosciences Profit Margin (Quarterly) : -140.7% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -140.7% |
| March 31, 2026 | -56.56% |
| December 31, 2025 | -75.57% |
| September 30, 2025 | -49.65% |
| June 30, 2025 | -116.7% |
| March 31, 2025 | -152.2% |
| December 31, 2024 | -162.5% |
| September 30, 2024 | -71.10% |
| June 30, 2024 | -175.4% |
| March 31, 2024 | -234.0% |
| December 31, 2023 | -174.3% |
| September 30, 2023 | -172.7% |
| June 30, 2023 | -161.4% |
| March 31, 2023 | -141.4% |
| December 31, 2022 | -304.4% |
| September 30, 2022 | -194.1% |
| June 30, 2022 | -641.3% |
| March 31, 2022 | -409.7% |
| December 31, 2021 | -553.7% |
| September 30, 2021 | -386.7% |
| June 30, 2021 | -384.8% |
| March 31, 2021 | -703.9% |
| December 31, 2020 | -793.1% |
| September 30, 2020 | -6.52K% |
| June 30, 2020 | -844.6% |
| Date | Value |
|---|---|
| March 31, 2020 | -2.08K% |
| December 31, 2019 | -6.84K% |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 59.27% |
| September 30, 2017 | -2.65K% |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | -13.04% |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -237.8% |
| Oncolytics Biotech, Inc. | -- |
| Sangamo Therapeutics, Inc. | -2.15K% |
| Sarepta Therapeutics, Inc. | -1.22% |
| Anixa Biosciences, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -42.93% |
| Return on Assets | -36.76% |
| Return on Invested Capital | -42.93% |
| Operating Margin (Quarterly) | -147.1% |
| Return on Net Operating Assets | -1.32K% |